Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of an adjuvanted recombinant protein COVID-19 vaccine in adults
PACTR202011523101903Phase 3Unknown
- Start
- Dec 2020
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) (2 arms). Primary endpoint: Clinical efficacy against symptomatic COVID-19 after second injection. Status: unknown.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202011523101903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202011523101903.